12936 Results

People

  1. Weigelt
    Weigelt
  2. Reis-Filho
    Reis-Filho
  3. Gonen
    Gonen
  4. Ladanyi
    Ladanyi
  5. Berger
    Berger
  6. Deasy
    Deasy
  7. Solit
    Solit
  8. Lewis
    Lewis
  9. Schultz
    Schultz
  10. De Stanchina
    De Stanchina

Groups

  1. Sloan Kettering Institute Postdocs (12936)
  2. GSK Faculty (6210)
  3. Department of Medicine (4656)
  4. Sloan Kettering Institute Faculty (3490)
  5. Surgery (2557)
  6. Solid Tumor Oncology Division (2525)
  7. Department of Pathology and Laboratory Medicine (2500)
  8. Center for Hematologic Malignancies (2324)
  9. Epidemiology and Biostatistics (1997)
  10. Human Oncology and Pathogenesis Program (1984)
  1. "Sloan Kettering Institute Postdocs"
Formats
  1. Journal Article (7820)
  2. Meeting Abstract (3612)
  3. Review (610)
  4. Editorial (251)
  5. Book Section (189)
  6. Conference Paper (160)
  7. Research Letter (133)
  8. Correspondence (63)
  9. Miscellaneous (62)
  10. Guidelines (30)
  11. Book Whole (6)
Groups
  1. Sloan Kettering Institute Postdocs (12936)
  2. GSK Faculty (6210)
  3. Department of Medicine (4656)
  4. Sloan Kettering Institute Faculty (3490)
  5. Surgery (2557)
  6. Solid Tumor Oncology Division (2525)

More Groups

People
  1. Britta Weigelt (366)
  2. Jorge Reis-Filho (327)
  3. Mithat Gonen (309)
  4. Marc Ladanyi (304)
  5. Joseph Deasy (278)
  6. Michael Berger (278)

More People

Years
  1. 2025 (394)
  2. 2024 (1038)
  3. 2023 (1151)
  4. 2022 (1364)
  5. 2021 (1176)
  6. 2020 (1240)

More Years

Publications
  1. Blood (641)
  2. Cancer Research (542)
  3. Journal of Clinical Oncology (416)
  4. Journal of Nuclear Medicine (261)
  5. Annals of Surgical Oncology (257)
  6. Clinical Cancer Research (235)

More Publications

Publishers
  1. Nature Publishing Group (1308)
  2. Elsevier Inc. (1173)
  3. American Association for Cancer Research (1039)
  4. Springer (818)
  5. Cell Press (719)
  6. American Society of Hematology (697)

More Publishers

Results (12936)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Impact of interim PET on Hodgkin lymphoma treatment outcome and survival in clinical practice
    Meeting Abstract

    Zheng, S.; Gupta, K.; Goyal, P.; Nakajima, R.; Michaud, L.; Batlevi, C. L.; Hamlin, P. A.; Horwitz, S. M.; Kumar, A.; Matasar, M. J.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Landscape of targetable alterations discovered by next generation sequencing demonstrates the role a community hospital can play in precision-guided oncology: Experience from Lenox Hill Hospital
    Meeting Abstract

    Vojnic, M.; Steinberg, J.; Odintsov, I.; Ziemba, Y.; Hill, L. K.; Vele, O.; Brunckhorst, K. R.; Hasanovic, A.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Heterogeneity of PD-L1 expression between primary and metastatic bladder cancer tumors and therapeutic implications between the immune cell score and combined positivity score
    Meeting Abstract

    Schulz, G. B.; Todorova, R.; Rodler, S.; Grimm, T.; Staehler, M. D.; Mayr, D.; Stief, C. G.; Casuscelli, J.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • A genomic blood test (NETest) identifies neuroendocrine transformation of prostate cancer
    Meeting Abstract

    Rahbar, K.; Kidd, M. S.; Drozdov, I. A.; Malczewska, A.; Bodei, L.; Rajwa, P.; Boegemann, M.; Bernemann, C.; Kitz, A.; Modlin, I. M.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Automated identification of lymphoma involving the bone from PET/CT reports using natural language processing and adaptive learning
    Meeting Abstract

    Navitski, A.; Goyal, P.; Ahsanuddin, S.; Zheng, S.; Joffe, E.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Do differences in the microbiome explain early onset in colon cancer?
    Meeting Abstract

    Keshinro, A.; Vanderbilt, C.; Stadler, Z. K.; Shia, J.; Gonen, M.; Chen, C. T.; Cercek, A.; Mendelsohn, R. B.; Yaeger, R.; Zehir, A.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • A phase I and randomized phase II etctn study of KW-0761 (Mogamulizumab) and MK-3475 (Pembrolizumab) in relapsed and refractory diffuse large B-cell lymphoma
    Meeting Abstract

    Joffe, E.; Vardhana, S. A.; Kumar, A.; Abedi, M.; Hoeg, R.; Sharon, E.; Younes, A.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Post-transplant lymphoproliferative disorder (PTLD) after solid organ transplant (SOT): A multicenter real world analysis (RWA) of 877 patients (pts) treated in the modern era
    Meeting Abstract

    Jagadeesh, D.; Tsai, D. E.; Wei, W.; Bustamante, J. A.; Wagner-Johnston, N. D.; Berg, S.; Kim, S. H.; Reddy, N. M.; Sriram, D.; Portell, C.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Symptomatic delayed seromas vs incidental findings on MR, and likelihood of BIA-ALCL in women with textured implants
    Meeting Abstract

    Ghione, P.; Sutton, E. J.; Hu, Q.; Galasso, N.; Ganesan, N.; Tyagi, N.; Martinez, D. F.; Dogan, A.; Morris, E. A.; Horwitz, S. M.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Evaluation of immune-related adverse events (irAE): Utilizing the patient-reported outcomes of the common terminology criteria for adverse events (PRO-CTCAE) in a phase II study of ipilimumab (ipi) in men with castration-sensitive prostate cancer (CSPC)
    Meeting Abstract

    Vargas Pivato de Almeida, D.; Anderson, J.; Danila, D. C.; Morris, M. J.; Slovin, S. F.; Abida, W.; Dayan, E. S.; Curley, T.; Arauz, G.; Baser, R. E.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save